Connor, Clark & Lunn Investment Management (CC&L)
AVNS

Connor, Clark & Lunn Investment Management (CC&L)’s Avanos Medical AVNS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,668
Closed -$1.1M – 1410
2024
Q3 		$1.1M Buy
45,668
+16,929
+59% +$387K 0.01% 856
2024
Q2 		$572K Buy
28,739
+8,210
+40% +$160K ﹤0.01% 1020
2024
Q1 		$409K Sell
20,529
-1,440
-7% -$27.8K ﹤0.01% 1183
2023
Q4 		$493K Buy
21,969
+1,247
+6% +$25.7K ﹤0.01% 1049
2023
Q3 		$419K Buy
20,722
+504
+2% +$11.4K ﹤0.01% 1062
2023
Q2 		$517K Buy
+20,218
New +$532K ﹤0.01% 976
2022
Q2 		– Sell
-9,373
Closed -$314K – 1036
2022
Q1 		$314K Buy
+9,373
New +$302K ﹤0.01% 864
2019
Q2 		– Sell
-5,400
Closed -$230K – 981
2019
Q1 		$230K Buy
+5,400
New +$242K ﹤0.01% 803
2018
Q1 		– Sell
-37,617
Closed -$1.74M – 715
2017
Q4 		$1.74M Sell
37,617
-52,126
-58% -$2.4M 0.01% 438
2017
Q3 		$4.04M Sell
89,743
-72,675
-45% -$3.1M 0.02% 326
2017
Q2 		$6.38M Buy
162,418
+25,725
+19% +$972K 0.04% 241
2017
Q1 		$5.21M Sell
136,693
-900
-0.7% -$35.1K 0.03% 245
2016
Q4 		$5.09M Buy
137,593
+20,500
+18% +$733K 0.03% 249
2016
Q3 		$4.06M Buy
117,093
+20,300
+21% +$711K 0.03% 271
2016
Q2 		$3.15M Buy
96,793
+18,700
+24% +$573K 0.02% 297
2016
Q1 		$2.24M Buy
78,093
+37,125
+91% +$989K 0.02% 321
2015
Q4 		$1.37M Buy
+40,968
New +$1.27M 0.01% 396

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AVNS Position: Q4 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 45,668 shares — an estimated $1.1M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AVNS in Q4 2015 and held it in 17 quarters. The position peaked at $6.38M in Q2 2017. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 45,668 Avanos Medical shares in Q4 2024, an estimated $1.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Avanos Medical in Q4 2015 and held it in 17 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Avanos Medical position peaked at $6.38M in Q2 2017.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.